Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S C Threlkeld

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
The Medical Clinics of North America|November 1, 1996
Antiretroviral therapyS C Threlkeld, M S Hirsch
Current Clinical Topics in Infectious Diseases|January 1, 1997
Update on management of patients with Nocardia infectionS C Threlkeld, D C Hooper
The Journal of Infectious Diseases|June 1, 1989
Biologic potential of amantadine-resistant influenza A virus in an avian modelW J Bean, S C Threlkeld, R G Webster
Journal of Immunology (Baltimore, Md. : 1950)|August 15, 1997
Degenerate and promiscuous recognition by CTL of peptides presented by the MHC class I A3-like superfamily: implications for vaccine developmentS C Threlkeld, P A Wentworth, S A Kalams, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
The Medical Clinics of North America|November 1, 1996
Antiretroviral therapyS C Threlkeld, M S Hirsch
Current Clinical Topics in Infectious Diseases|January 1, 1997
Update on management of patients with Nocardia infectionS C Threlkeld, D C Hooper
The Journal of Infectious Diseases|June 1, 1989
Biologic potential of amantadine-resistant influenza A virus in an avian modelW J Bean, S C Threlkeld, R G Webster
Journal of Immunology (Baltimore, Md. : 1950)|August 15, 1997
Degenerate and promiscuous recognition by CTL of peptides presented by the MHC class I A3-like superfamily: implications for vaccine developmentS C Threlkeld, P A Wentworth, S A Kalams, et al.
Pageof 1